Craig C. Hopkinson
Evp R&D, Chief Medical Officer at Alkermes plc. (ALKS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 1SEC | ALKSAlkermes plc. | Sell Plan | 9,00065,389 held (−12%) | $46.99 | $423K | -13.6% |
| Aug 3SEC | ALKSAlkermes plc. | Sell Plan | 9,00069,389 held (−11%) | $48.58 | $437K | -16.4% |
| Jul 1SEC | ALKSAlkermes plc. | Sell Plan | 8,30074,089 held (−10%) | $51.46 | $427K | -21.1% |
| Jul 1SEC | ALKSAlkermes plc. | Sell Plan | 70073,389 held (−1%) | $52.13 | $36K | -22.1% |
| Jun 1SEC | ALKSAlkermes plc. | Sell Plan | 9,00077,389 held (−10%) | $41.67 | $375K | -2.5% |
| May 1SEC | ALKSAlkermes plc. | Sell Plan | 9,00081,389 held (−10%) | $33.40 | $301K | +21.6% |
| Apr 1SEC | ALKSAlkermes plc. | Sell Plan | 9,00085,389 held (−10%) | $35.51 | $320K | +14.4% |
| Mar 4SEC | ALKSAlkermes plc. | Sell Plan | 9,00089,389 held (−9%) | $29.72 | $267K | +36.6% |
| Feb 2SEC | ALKSAlkermes plc. | Sell Plan | 5,00061,740 held (−7%) | $34.24 | $171K | +18.6% |
| Feb 2SEC | ALKSAlkermes plc. | Sell Plan | 4,00057,740 held (−6%) | $33.54 | $134K | +21.1% |
| Jan 8SEC | ALKSAlkermes plc. | Sell Plan | 5,00061,740 held (−7%) | $30.00 | $150K | +35.4% |
| Jan 2SEC | ALKSAlkermes plc. | Sell Plan | 4,00061,740 held (−6%) | $28.00 | $112K | +45.0% |
| Dec 5SEC | ALKSAlkermes plc. | Sell Plan | 3,74865,740 held (−5%) | $30.00 | $112K | +35.4% |
| Dec 1SEC | ALKSAlkermes plc. | Sell Plan | 4,00065,740 held (−6%) | $29.30 | $117K | +38.6% |
| Nov 3SEC | ALKSAlkermes plc. | Sell Plan | 9,00069,740 held (−11%) | $30.38 | $273K | +33.7% |
| Oct 15SEC | ALKSAlkermes plc. | Sell Plan | 9,00073,740 held (−11%) | $31.53 | $284K | +28.8% |
- Sell
Evp R&D, Chief Medical Officer Craig C. Hopkinson sold $423K of ALKS at $46.99 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp R&D, Chief Medical Officer Craig C. Hopkinson sold $437K of ALKS at $48.58 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp R&D, Chief Medical Officer Craig C. Hopkinson sold $427K of ALKS at $51.46 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp R&D, Chief Medical Officer Craig C. Hopkinson sold $36K of ALKS at $52.13 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp R&D, Chief Medical Officer Craig C. Hopkinson sold $375K of ALKS at $41.67 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp R&D, Chief Medical Officer Craig C. Hopkinson sold $301K of ALKS at $33.40 — pre-scheduled 10b5-1 plan sale.